Author

Shelley R. Hoyer

Observed name: Shelley R Hoyer

Observed institution: Prevention Group

OpenAlex ID: A5060884347

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

2021 · Christine G. Lee, Brandy Heckman-Stoddard, et al. · Diabetes Care · 102

The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures

2020 · Andrea M. Kriska, Bonny Rockette-Wagner, et al. · Diabetes Care · 70

Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience

2022 · Neil H. White, Qing Pan, et al. · Diabetes Care · 34

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

2025 · Jill P. Crandall, Dana Dabelea, et al. · Diabetes Care · 28

Association of Metformin With the Development of Age-Related Macular Degeneration

2022 · Amitha Domalpally, Samuel A. Whittier, et al. · JAMA Ophthalmology · 25

Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)

2022 · Josephine H. Li, James A. Perry, et al. · Diabetes · 20

Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH

2023 · Josephine H. Li, Laura N. Brenner, et al. · Diabetologia · 19

Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure

2024 · Christine G. Lee, Adam Ciarleglio, et al. · Diabetes Care · 10

Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks

2025 · Emily Kobayashi, Nathaniel J. Linden-Santangeli, et al. · Diabetes Care · 9

The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience

2022 · Neil H. White, Qing Pan, et al. · Diabetes Care · 8

The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)

2022 · Marissa M. Shams-White, Ashley H. Tjaden, et al. · BMC Nutrition · 5

Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes

2026 · Marcel E. Salive, Ashley H. Tjaden, et al. · JAMA · 3

Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS)

2025 · Ashley H. Tjaden, Barbara H. Braffett, et al. · Diabetes Care · 2

Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study

2025 · William H. Herman, Adam Ciarleglio, et al. · Diabetes Care · 2

Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study

2025 · Samuel Dagogo-Jack, Erin J. Kazemi, et al. · Diabetes Care

Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study

2025 · William C. Knowler, Qing Pan, et al. · Diabetes Care

Works count: 16

Citation count: 337

H-index: 9

I10-index: 8